Introduction to Clinical Trials: Exploring the Frontiers of Medical Research
This introduction to clinical trials is designed for anyone seeking to understand how medical research works — whether you are a patient considering participation or a sponsor evaluating a research partner. At FOMAT Medical, clinical trials are not just our business — they are our mission. As an embedded research organization with over a decade of experience conducting Phase 1 through Phase 4 studies across multiple therapeutic areas, we understand firsthand how the process works and why it matters.
Clinical trials are the backbone of medical research, playing a pivotal role in advancing healthcare and improving patient outcomes. These carefully designed studies evaluate the safety, effectiveness, and side effects of new treatments, interventions, or diagnostic methods. They provide a crucial bridge between scientific discovery and real world application, offering hope for the development of innovative therapies.
This introduction to clinical trials will cover the different types of studies, the phases involved, how participants are selected, and how long the process typically takes.
What Are Clinical Trials?
A foundational part of any introduction to clinical trials is understanding what they are and how they are structured. Clinical trials are research studies conducted to evaluate the safety, effectiveness, and side effects of new medical treatments, interventions, or therapies. They gather scientific evidence to determine the benefits and risks of a specific intervention and to assess its impact on human health.
Clinical trials are performed in several phases, each designed to answer specific research questions and provide increasing levels of evidence.
Phase 0
Also known as exploratory studies, Phase 0 trials involve a small number of participants and aim to gather preliminary data on how a drug or treatment behaves in the human body. They may involve microdoses of the treatment to assess its pharmacokinetics.
Phase 1
Phase 1 trials focus on determining the safety and dosage range of the treatment. They involve a small number of healthy volunteers or individuals with the target condition. Researchers closely monitor participants for any adverse effects and collect data on how the treatment is metabolized and tolerated.
Phase 2
In Phase 2 trials, the treatment is administered to a larger group of individuals who have the condition being studied. These trials further evaluate the treatment’s effectiveness and side effects, and researchers may explore different dosages.
Phase 3
Phase 3 trials involve a larger number of participants and compare the new treatment with existing standard treatments or a placebo. These trials gather comprehensive data on safety, efficacy, and potential side effects, providing critical evidence for regulatory approval.
Phase 4
Also known as post marketing surveillance trials, Phase 4 studies are conducted after a treatment has been approved and made available to the public. They monitor the long term safety and effectiveness of the treatment in a larger population.
Clinical trials are conducted according to strict protocols and ethical guidelines. Participants are provided with informed consent and closely monitored throughout the study.
How Are People Chosen for Clinical Trials?
An important aspect of any introduction to clinical trials is understanding how participants are selected. People are chosen through a process called participant recruitment, designed to ensure that participants are suitable for the study and that results are meaningful and applicable to the target population.
Inclusion Criteria
These are the characteristics or conditions that individuals must possess to be eligible. Inclusion criteria can include factors such as age, gender, specific medical conditions, disease severity, previous treatments received, and overall health status.
Exclusion Criteria
These are the factors or conditions that disqualify individuals from participating. Exclusion criteria may include medical conditions or treatments that could interfere with study results, known allergies to the treatment being tested, or factors that may pose risks to participant safety.
Recruitment Methods
Researchers use various methods to identify potential participants including reaching out to healthcare providers, advertising through traditional and online platforms, collaborating with patient advocacy groups, and using registries designed to connect potential participants with available studies.
Screening and Informed Consent
Potential participants undergo a screening process to assess their eligibility. Those who meet the criteria are provided with detailed information about the trial including its purpose, procedures, potential risks and benefits, and the rights and responsibilities of participants. They are given the opportunity to ask questions and provide informed consent before deciding to participate.
What Are the 4 Types of Clinical Trials?
A complete introduction to clinical trials includes understanding the four main types of studies.
Treatment Trials
These trials evaluate the effectiveness and safety of new treatments or interventions such as medications, surgical procedures, or therapies. Treatment trials determine whether a new approach is more effective than existing standard treatments or a placebo.
Prevention Trials
Prevention trials focus on identifying ways to prevent the development or recurrence of a particular condition. These trials often involve medications, lifestyle modifications, or behavioral interventions in individuals who are at risk of developing the condition.
Diagnostic Trials
Diagnostic trials aim to improve the accuracy and efficiency of diagnostic tests or procedures used to identify specific conditions. These trials evaluate new diagnostic techniques, biomarkers, imaging modalities, or algorithms to improve the accuracy of disease detection.
Screening Trials
Screening trials evaluate the effectiveness of population wide screening programs to identify individuals at risk of a particular disease. They aim to determine the benefits and potential harms of implementing screening programs in terms of early detection, improved outcomes, and cost effectiveness.
How Long Do Clinical Trials Take?
Understanding timelines is an essential part of any introduction to clinical trials. Duration varies significantly depending on the phase, the nature of the condition being studied, the number of participants involved, and the specific objectives.
Phase 1 trials typically last a few months to a year, involving a small number of participants focused primarily on safety and dosage evaluation.
Phase 2 trials usually last several months to two years, involving a larger number of participants to assess effectiveness and continue monitoring safety.
Phase 3 trials are generally the longest phase, ranging from one to several years. They involve a large number of participants and compare the new treatment to existing standards to support regulatory approval.
Phase 4 trials are conducted after approval and can vary widely in duration depending on the specific research objectives and the need to collect real world data over an extended period.
It is important to note that clinical trial durations are estimates. Unforeseen circumstances, participant recruitment timelines, data analysis, and regulatory approval processes can all impact the overall timeline.
According to the U.S. National Library of Medicine, there are hundreds of thousands of active and recruiting studies registered globally at any given time — a reflection of the enormous scale of ongoing medical research.
For those interested in participating, our article on paid clinical trials covers compensation structures and what participants can expect. You can also explore FOMAT’s currently enrolling studies directly on our patient active studies page.
Conclusion
This introduction to clinical trials has covered the essential elements of how medical research studies are structured, conducted, and carried out. From the four phases of development to participant selection, study types, and timelines, understanding the process helps patients, families, and healthcare partners engage more meaningfully with medical research.
At FOMAT Medical, we are committed to conducting rigorous, ethical, and impactful clinical trials that advance medicine and improve patient lives. If you are interested in learning more or exploring participation, we invite you to reach out and take the first step.